✦ LIBER ✦

Studies on components of the contact phase system in patients with advanced gastrointestinal cancer

✍ Scribed by Olav Roeise; Steinar Sivertsen; Tom Erik Ruud; Bonno N. Bouma; Jan O. Stadaas; Ansgar O. Aasen

Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 449 KB
Volume: 65
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19900315)65:6<1355::aid-cncr2820650618>3.0.co;2-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of doxorubicin plus ifosf

Phase II study of doxorubicin plus ifosfamide/mesna in patients with advanced breast cancer

✍ Michael J. Millward; Adrian L. Harris; Brian M. J. Cantwell 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 429 KB 👁 1 views

A phase II study of piritrexim in patien

A phase II study of piritrexim in patients with advanced squamous head and neck cancer

✍ Wu-Ching Uen; Andrew T. Huang; Robert Mennel; Stephen E. Jones; Monica B. Spauld 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 347 KB 👁 2 views

Piritrexim (PTX) is a newly developed lipid-soluble folate antagonist that crosses the cell membrane by a simple, rapid, carrier-independent diffusion process. A Phase II study was conducted to evaluate the activity of PTX in 34 patients with previously chemotherapy-naive squamous cell cancer of the

A phase I study of chronic daily dosing

A phase I study of chronic daily dosing of oral etoposide in combination with cisplatin for patients with advanced cancer

✍ Masahiro Fukuoka; Noriyuki Masuda; Shunichi Negoro; Minoru Takada; Shinzoh Kudoh 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 440 KB 👁 2 views

Ex vivo ras peptide vaccination in patie

Ex vivo ras peptide vaccination in patients with advanced pancreatic cancer: Results of a phase I/II study

✍ Marianne K. Gjertsen; Arne Bakka; Jarle Breivik; Ingvil Saeterdal; Tobias Gedde- 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 434 KB 👁 2 views

In a pilot phase 1/11 study we have tested synthetic ras peptides used as a cancer vaccine in 5 patients with advanced pancreatic carcinoma. The treatment principle used was based on loading professional antigen-presenting cells (APCs) from peripheral blood with a synthetic ras peptide corresponding

Phase II study of gemcitabine and cispla

Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinoma

✍ Philip A. Philip; Mark M. Zalupski; V. K. Vaitkevicius; Patricia Arlauskas; Ruth 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 2 views

Phase II study of 5-fluorouracil and fol

Phase II study of 5-fluorouracil and folinic acid in the treatment of patients with advanced gastric cancer: A Southwest Oncology Group study

✍ Giuseppe Colucci 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 2 views

n the article published in Cancer entitled "Phase I1 study of 5-fluoro-I uracil and folinic acid in the treatment of patients with advanced gastric cancer. A Southwest Oncology Group Study,"' the authors erroneously quoted the results of our study and we request a correction. In the results of our